Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial-Reference-Cited by-同舟云学术

Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnetic resonance. The MASS-V Trial

Published:2012-08-16 Issue:1 Volume:12 Page:
ISSN:1471-2261
Container-title:BMC Cardiovascular Disorders
language:en
Short-container-title:BMC Cardiovasc Disord

Author:

Hueb Whady, ,Gersh Bernard J,Rezende Paulo Cury,Garzillo Cibele Larrosa,Lima Eduardo Gomes,Vieira Ricardo D'Oliveira,Garcia Rosa Maria Rahmi,Favarato Desiderio,Segre Carlos Alexandre W,Pereira Alexandre Costa,Soares Paulo Rogério,Ribeiro Expedito,Lemos Pedro,Perin Marco A,Strunz Célia Cassaro,Dallan Luis AO,Jatene Fabio B,Stolf Noedir AG,Hueb Alexandre Ciappina,Dias Ricardo,Gaiotto Fabio A,da Costa Leandro Menezes Alves,Oikawa Fernando Teiichi Costa,de Melo Rodrigo Morel Vieira,Serrano Carlos Vicente,de Ávila Luiz Francisco Rodrigues,Villa Alexandre Volney,Filho José Rodrigues Parga,Nomura César,Ramires José AF,Filho Roberto Kalil

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1186/1471-2261-12-65/fulltext.html

Reference8 articles.

1. Thygesen K: Alpert JS. White HD: Universal definition of myocardial infarction. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J. 2007, 28: 2525-2538.

2. Porto I, Selvanayagam JB, Van Gaal WJ, Prati F, Cheng A, Channon K, Neubauer S, Banning AP: Plaque volume and occurrence and location of peri procedural myocardial necrosis after percutaneous coronary intervention: insights from delayed enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006, 114: 662-669. 10.1161/CIRCULATIONAHA.105.593210.

3. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Roger VL, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J: Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010, 121 (7): e46-e215.

4. Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW: Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol. 2009, 54: 477-486. 10.1016/j.jacc.2009.03.063.

5. Prasad A, Herrmann J: Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011, 364: 453-464. 10.1056/NEJMra0912134.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Right atrial wall inflammation detected by 18F-FDG PET/CT may be significantly associated with persistent atrial fibrillation: a prospective case-control study;BMC Cardiovascular Disorders;2023-11-30

2. Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease;Medicine;2023-04-21

3. Cardiac Troponin I in Patients Undergoing Percutaneous and Surgical Myocardial Revascularization: Comparison of Analytical Methods;Diagnostics;2023-04-01

4. Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts;Acta Pharmaceutica Sinica B;2022-10

5. Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model;Drug Metabolism and Disposition;2020-09-01